GENEVA, Dec. 31 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2025/034720) for "ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING A NAPHTHYRIDINE COMPOUND" on Jun 23, 2025. With publication no. WO/2025/265110, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ALVAREZ-NUNEZ, Fernando, Antonio (C/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799), CHUNG, John, Inn (C/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799)...